Telix Pharmaceuticals
ISIN AU000000TLX2
|WKN A2H7JK
Overview
Description
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialisation. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TX250, TX591, and TX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
Healthcare Healthcare Equipment Other Medical Devices Australia
Financials
Key metrics
| Market capitalisation, EUR | 2,983.17 m |
| EPS, EUR | - |
| P/B ratio | 32.35 |
| P/E ratio | 912.88 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 308.86 m |
| Net income, EUR | 3.20 m |
| Profit margin | 1.04% |
What ETF is Telix Pharmaceuticals in?
There are 11 ETFs which contain Telix Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Telix Pharmaceuticals is the HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 1.46% | Equity World Health Care Equal Weighted Innovation | 217 | 0.59% | 14 | -8.70% | A2PFPC | IE00BJQTJ848 |
| SPDR MSCI ACWI IMI UCITS ETF | 0.01% | Equity World | 3,518 | 0.17% | 1,279 | +23.93% | A1JJTD | IE00B3YLTY66 |
| Fidelity Sustainable Research Enhanced Pacific ex-Japan Equity UCITS ETF Acc | 0.31% | Equity Asia Pacific Social/Environmental | 111 | 0.30% | 305 | +2.93% | A2QD42 | IE00BNGFMY78 |
| SPDR MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,417 | 0.45% | 750 | +16.21% | A1W56P | IE00BCBJG560 |
| Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing | 0.02% | Equity Asia Pacific Social/Environmental | 2,112 | 0.17% | 16 | +12.64% | A3DJRB | IE0008T6IUX0 |
| iShares MSCI World Small Cap UCITS ETF | 0.03% | Equity World Small Cap | 3,376 | 0.35% | 3,499 | +15.71% | A2DWBY | IE00BF4RFH31 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,853 | 0.24% | 268 | +25.17% | A2QL8V | IE00BNG8L385 |
| Invesco Dow Jones Islamic Global Developed Markets UCITS ETF Acc | 0.01% | Equity World Islamic Investing | 1,778 | 0.40% | - | +28.39% | A3C6Z0 | IE000UOXRAM8 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,853 | 0.24% | 322 | +25.23% | A2QL8U | IE00BNG8L278 |
| Xtrackers S&P/ASX 200 UCITS ETF 1D | 0.15% | Equity Australia | 200 | 0.50% | 56 | +9.24% | DBX1A2 | LU0328474803 |
| Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Accumulating | 0.02% | Equity Asia Pacific Social/Environmental | 2,112 | 0.17% | 23 | +12.66% | A3DJRA | IE000GOJO2A3 |
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.